MyWallSt
Stock Club
Welcome to the Stock Club podcast, where we bring you weekly episodes on the most significant changes in the world of investing. Delve into the inner workings of investing, stock news and strategies, all geared towards helping you become a better investor. Join the MyWallSt team, as they sit down to share the latest investing stories. If you want to stay ahead in the game, this podcast is for you.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
The Stocks Quietly Beating Nvidia in 2026 | Stock Club 319 09.07.2026 47:01
Investicon is coming to Dublin on August 27th, info and tickets at https://www.investicon.ie/ or email brian@mywallst.com for tickets and early bird codes. Subscribe to Prophet: UseProphet.com or email Frank@mywallst.comAt MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and...
Bending Spoons: The Company Behind Vimeo, Evernote and AOL Is About to Go Public | Stock Club 318 02.07.2026 34:50
At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years....
#317: Our Favorite Japanese Stocks 25.06.2026 42:04
This week, Mike and Emmet head to Japan in search of overlooked growth stocks. Japan is home to some of the world's oldest businesses, with more than 140 companies claiming histories of over 500 years. Many of them have survived by following two simple rules: hold plenty of cash and avoid debt. But after decades of economic stagnation, a new wave of corporate reforms is pushing Japanese busine...
#316: How to Find 100-Bagger Stocks (w/ Neeraj Khemlani and Matthew Ankrom) 18.06.2026 54:50
This week, Mike sits down with Neeraj Khemlani and Matthew Ankrom, the minds behind The Coffee Can Investor , to discuss one of our favorite investing topics: finding and holding stocks capable of returning 100x. We open with Neeraj and Matthew walking us through the story behind the "coffee can" strategy. Inspired by an old investing experiment, Matt set out to build the ultimate long-term portf...
#315: How to Invest Through Booms, Busts & Bubbles (w/ Ben Carlson) 11.06.2026 47:30
This week, Mike sits down with investor and author Ben Carlson to discuss the habits, mindsets, and mistakes that define successful investing. We start with the two variables Ben believes matter more than anything else: your time horizon and your risk profile. While most investors focus on picking the right stocks, Ben argues that understanding your willingness, need, and ability to take risk is f...
#314: Can SpaceX Really Be Worth $2 Trillion? 04.06.2026 44:12
Ahead of its highly anticipated IPO, SpaceX is reportedly targeting a valuation between $1.75 trillion and $2 trillion, numbers that would make it one of the largest public companies in the world from day one. This week, Mike and Emmet ask: does the business justify the hype? In 2025, revenue reached $18.7 billion, up 33% year over year. But the company also posted a net loss of roughly $5 billion...
#313: Wall Street's Craziest Stories 28.05.2026 45:23
This week, Mike and Emmet share some of the craziest stories in stock market history. Starting with a chimpanzee named Raven, who became a star during the dot-com bubble. After throwing darts at a board of internet stocks, her assembled portfolio returned 213% in 1999, making her the 22nd most successful money manager in the United States that year. Then there’s the story of Jonathan Lebed — essen...
#312: Cerebras: 2026's biggest IPO? 21.05.2026 38:58
This week, we dive into one of the hottest new companies in AI and the market: Cerebras (CBRS). The company only just IPO’d, but it’s already valued at close to $100 billion. Even more astonishing? Cerebras was founded just 11 years ago by five engineers. Its core thesis is radical: the architecture underpinning AI computing is fundamentally flawed. Cerebras argues that GPUs—the chips powering tod...
#311: Are We in an AI Bubble? 14.05.2026 39:45
The market is on an absolute tear right now, and it’s raising some serious questions. Lucky for you, Mike and Emmet want to upack them all. Despite the crazy macroeconomic conditions, the market keeps performing. The Nasdaq Composite is up roughly 38% in the last year. And when you zoom in on individual stocks, things get even crazier. SanDisk (SNDK) is up 63% in a month, 450% in six months, and a...
#310: Modern Value Investing w/ Jose Mayora 07.05.2026 45:19
The typical definition of Value Investing: Buying an asset for less than it’s truly worth. But according to this week’s guest Jose Najarro, the concept is widely misunderstood. Too often, value investing is associated with older, slower companies, think utilities, and traditional metrics like low price-to-earnings or price-to-book ratios. But those alone don’t define value. Every valuation comes w...
#309: 2 Legacy Stocks for Long-term Investing 30.04.2026 43:30
With all the talk of IPOs and upstarts, it’s a great time to remember that legacy players can still pack a punch. This week, we look at two companies that have been on public markets for decades and have been all over the headlines lately: Intel(NASDAQ: INTC) and Berkshire Hathaway (NYSE: BRK.B). Intel has been on the Stock Club radar for about nine months, when it was first pitched by Clem Chambe...
#308: The Best and Worst Business Pivots 23.04.2026 46:15
In light of Allbirds’ (NASDAQ: BIRD) head-scratching transition to an AI compute infrastructure company, Mike and Emmet break down some of the market’s best and worst business pivots. In simple terms, a pivot is when a business decides to stop doing what it’s known for and pursue something else. This can be proactive, like Slack giving up its gaming business to develop its internal communication t...
#307: Is SpaceX’s IPO a Buy? 16.04.2026 50:49
This week, we’re discussing one of the most significant IPOs of all time: SpaceX. While space travel began as a government-led effort, over the past few decades it has increasingly become the domain of the private sector. For those who need a refresher on the business of space—and SpaceX specifically—Emmet has you covered with a detailed preamble. SpaceX consists of three core businesses: rocket l...
#306: Ireland’s New Investment Scheme Explained 09.04.2026 38:09
The day we’ve been hoping for is finally here. The Irish government has announced a new investing scheme to provide people in Ireland with an easy, tax-efficient way to access the markets. There are hundreds of billions of euros sitting in Irish current accounts, and it’s time they get to work. Back by popular demand, Dave Quinn from Investwise joins us to break down why these accounts are being i...
Stock Red Flags to Avoid Before They Destroy Your Portfolio 02.04.2026 47:17
We normally talk about the characteristics we love to find in stocks. But this week, we bring you all the things we hate. We’ve all gotten caught in a hype cycle or seen an investment thesis degrade, so having a list of red flags to look for is a great way to check in with your portfolio. They include: Over-promising. It can be hard to spot fraud in the early days, but if a company is hyperbolic...
2 Australian (ASX) Stocks to Buy Right Now 26.03.2026 40:01
Investor Down Under — g’day. We’ve long loved hunting for underappreciated stocks abroad, and over the years we’ve realized Australia is a particularly great place to find them. With its investing culture on the rise, this week we’re highlighting some of our local favorites. Emmet brings you a “high-quality moonshot with revenue.” Out of character for him, it’s Telix Pharmaceuticals (ASX: TLX). He...
#303: The AI Stocks No One is Talking About: Biotech Boom 19.03.2026 47:38
This week, Emmet and Mike are digging into one of the hottest trends of our futuristic world: human longevity. We’ve all seen Bryan Johnson on our social feeds, but the business of living longer is more than just a meme. Today, new-age pharmaceutical companies are leveraging AI to reinvent the drug development process—making it faster, cheaper, and more customizable. If they’re successful, it coul...
#302: The One Metric You Need to Find Multibagger Stocks 12.03.2026 45:29
We’ve pitched you businesses and described graphs, but this week Mike and Emmet put the power in your hands and teach you how to find multibagger stocks. And it can be as simple as one metric: insider ownership. Inspired by the beloved book Investment Intelligence , we show you how to monitor and understand insider buying. This includes which executives to pay special attention to, how much is co...
#301: The 6 Best Dividend Stocks to Buy 05.03.2026 54:02
This week, we’re heading to safer shores — trading moonshots for mailboxes — and bringing you Emmet and Mike’s favorite dividend stocks. We’re growth investors at heart and would usually rather see smart R&D spending than dividend distributions. But for many investors, especially those approaching retirement, a few value stocks can be a smart addition to a portfolio. Emmet walks us through why...
#300: The One, Life-Changing Stock to Buy and Hold for the Next 10 Years 26.02.2026 59:24
To celebrate Stock Club’s 300th episode, Emmet and Mike attempt to find the next Nvidia. The idea spawned from a portfolio Emmet assembled back in 2019 in our early episode: “13 Stocks That Could Be the Next Netflix or Dell.” These represent the golden gooses of his investing career and prove it only takes one great stock to change your life. The original lineup included Shopify (SHOP), iRobot (...
#299: What Autonomous Driving Stocks You Should Buy (and Tesla Isn’t One) (w/ Derek Reilly) 19.02.2026 42:08
There are three princes in the autonomous taxi race: Google’s Waymo, Tesla, and Amazon’s Zoox. But who will win and claim the crown? All the smartest investors want to know. Luckily for them, this week Derek Reilly drops by Stock Club, fresh off the CES trade show, where he saw the latest self-driving tech. Derek believes Waymo is the gold standard, having achieved Level 4 autonomy thanks to its u...
#298: What Software Stocks Should You Buy on the Dip? 12.02.2026 52:45
Salesforce, Workday, HubSpot, Atlassian, ServiceNow, Adobe, and more are all down in the dumps. Is the age of B2B software supremacy at an end? Long favored for their revenue growth and strong margin profiles, many of these stocks have benefited from (and struggled with) lofty valuations. But AI—and the advent of “vibe coding”—is putting their moats under threat, so Mike and Emmet dig in to determ...
#297: What Stocks to Buy During the AI Bubble (w/ Porter Stansberry) 05.02.2026 45:44
This week, Emmet is joined by a legend in financial publishing, Porter Stansberry . Porter is a master at recognizing and managing financial risk—and educating the public along the way. He even delivered positive returns during the 2008 financial crisis. Porter shares his bull and bear case for America, weighing freedom of opportunity against excessive borrowing. He’s wary of U.S. Treasuries and...
#296: Everything You Need to Know About Ireland’s Auto-Enrolment Pension Scheme 29.01.2026 42:48
If you are one of the 800,000 people in Ireland who do not have a workplace pension, your paycheck may be a bit lighter this month. This week, Ireland’s Auto-Enrolment Pension Scheme (a.k.a. MyFutureFund) launched, aiming to address the shortcomings of the State Pension. If you are part of this cohort, 1.5% of your gross salary is now being directed into a retirement account. Luckily for Stock Clu...
#295: Even Bolder Stock Buys for 2026!? 22.01.2026 59:49
If you thought last week was a treat, Mike and Emmet are here to double your luck. They bring you six more stocks to fill out your portfolio across different tastes and risk factors. Check in with your needs and add to your shortlists. We’ll pitch you: A Magnificent Seven member on the up and up in 2026 A biotech—reasonable or risky A stock with nothing to do with AI (no bubbles here) Magnificent...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.